Related NCI Initiatives
The National Cancer Institute has recognized that the achievement of 21st century personalized cancer care requires a commitment to a new kind of scientific enterprise. Such an enterprise is characterized by “team science” across multiple laboratories that share data in standardized formats; collaborations among academic, private, and public sector organizations; and high-throughput technology platforms supported by seamless informatics capability and systems-level planning and management. The technology initiatives launched through the NCI, including the Alliance for Nanotechnology in Cancer, are positioned to support this transformation in cancer research for better prevention, diagnosis, and treatment of cancer and improved outcomes for patients.
Learn more about NCI’s complementary initiatives by visiting their program Web sites:
- cancer Biomedical Informatics Grid (caBIG®)
- Clinical Proteomic Technologies Initiative for Cancer
- Innovative Molecular Analysis Technologies Program (IMAT)
- Office of Biorepositories and Biospecimen Research (OBBR)
- Office of Cancer Genomics (OCG)
- Physical Sciences in Oncology initiative
- Small Business Innovation Research & Small Business Technology Transfer Program
- Specialized Programs of Research Excellence (SPOREs)

